StonvexLoading…
StonvexStonvexStonvexCore line items from CTRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|---|
Revenue | $126.99M | $3.85M | $1.23M | $0.00 | $0.00 |
Operating Income | Not available | $81.78M | $325.29M | $65.19M | $124.40M |
Net Income | Not available | $80.21M | $320.54M | $65.80M | $125.08M |
EPS (Diluted) | $0.37 | $0.36 | $1.57 | $0.35 | $0.80 |
Total Assets | Not available | $5.24B | $5.15B | $3.88B | $3.44B |
Total Liabilities | Not available | $1.08B | $1.09B | $936.27M | $507.63M |
Cash & Equivalents | Not available | $223.21M | $198.04M | $26.51M | $213.82M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 226.53M | 222.75M | 187.67M | 186.99M |